Using machine learning to predict how people diagnosed with major depressive disorder respond to treatment
Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...
Healio12h
FDA approves Spravato as monotherapy for adults with major depressive disorder
The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...
Can Lexapro Cause Weight Loss? What to Know
If you’ve been diagnosed with major depressive disorder or a form of anxiety, your mental health provider may prescribe the ...
Labroots15h
Revealing a Molecule That Links the Gut Microbiome to Depression
While studies have associated Morganella morganii and major depressive disorder before, this study deciphers how they are ...
GlobalData on MSN16h
J&J’s Spravato receives FDA label expansion for depression monotherapy
Johnson & Johnson’s (J&J) nasal spray Spravato (esketamine) has received a label expansion, now approved as a monotherapy ...
Largest study on the genetics of bipolar disorder to date gives new insights into the underlying biology
Bipolar disorder is a complex psychiatric disorder, characterized by fluctuations between episodes of (hypo)mania and ...
Psychology Today1d
Signs and Symptoms of Depression
In some studies, as many as one third of people with major depressive disorder had symptoms of agitation and physical restlessness. They may range from frequent wringing of the hands and shuffling ...
Medscape3d
Efficacy, Safety and Tolerability of Escitalopram in Doses up to 50 mg in Major Depressive Disorder (MDD)
There is limited published data at higher doses and none in the treatment of Major Depressive Disorder (MDD). Methods This open-label, pilot study was designed to investigate the efficacy ...